What as‑needed (prn) oral acyclovir dosing regimen and quantity should be prescribed for an adult with normal renal function to treat recurrent herpes labialis (cold‑sore) outbreaks over several months without frequent refills?

PRN Acyclovir Dosing for Recurrent Cold Sores

For episodic treatment of recurrent herpes labialis, prescribe acyclovir 800 mg orally twice daily for 5 days, and dispense a 3–6 month supply (30–60 tablets) so the patient can self-initiate therapy at the first prodromal symptom without needing frequent refills. 1

Recommended Episodic Treatment Regimen

The FDA-approved and guideline-supported dosing options for recurrent cold sores include three equally effective 5-day regimens 1:

• Acyclovir 800 mg orally twice daily for 5 days (most convenient; 10 tablets per episode) 1, 2
• Acyclovir 400 mg orally three times daily for 5 days (15 tablets per episode) 1, 2
• Acyclovir 200 mg orally five times daily for 5 days (25 tablets per episode) 1, 2

The 800 mg twice-daily regimen offers the best balance of efficacy and adherence because it requires only two doses per day, reduces mean pain duration (2.5 vs 3.9 days with placebo), shortens symptom duration (8.1 vs 12.5 days), and prevents lesion development in 93% of treated patients. 1

Quantity to Prescribe for Multi-Month Supply

To avoid frequent refills while ensuring the patient has medication on hand for immediate self-treatment:

• Dispense 30–60 tablets (enough for 3–6 episodes at 10 tablets per episode) 1, 2
• Instruct the patient to initiate treatment during the prodrome (tingling, burning, itching) or within 24 hours of lesion onset, because peak viral titers occur in the first 24 hours and early intervention is critical for maximal benefit 1, 3
• Starting therapy after the first 24 hours markedly diminishes clinical efficacy 3

Patient Counseling and Self-Management

• Provide a standing prescription so the patient can begin therapy immediately at the first sign of an outbreak without calling for authorization 3
• Emphasize that acyclovir does not eradicate latent virus and does not affect the frequency or severity of future recurrences after discontinuation 1
• Advise the patient to avoid direct contact (kissing, sharing utensils) until all lesions are fully crusted, because viral shedding persists for approximately 6.4 days even with treatment 3
• Counsel on trigger avoidance: apply SPF ≥15 sunscreen or zinc oxide before UV exposure, and identify personal triggers such as fever, stress, or menstruation 3, 4

When to Consider Chronic Suppressive Therapy

If the patient experiences six or more episodes per year, switch from episodic to daily suppressive therapy 3, 5:

• Acyclovir 400 mg orally twice daily reduces recurrence frequency by ≥75% 3, 5
• Suppressive therapy has been shown safe for up to 6 years of continuous use 3, 5
• After 1 year of suppression, reassess recurrence rate and consider discontinuation 3

Renal Dosing Adjustments

For patients with renal impairment, adjust the 800 mg twice-daily regimen as follows 2:

Creatinine Clearance	Adjusted Dose
>25 mL/min	800 mg every 12 hours (no change)
10–25 mL/min	800 mg every 24 hours
<10 mL/min	800 mg every 24 hours

• Obtain baseline renal function in elderly patients (≥80 years) before prescribing to avoid drug accumulation and neurotoxicity 3

Common Pitfalls to Avoid

• Do not prescribe topical acyclovir for episodic treatment; oral therapy is significantly more effective 1, 3
• Do not delay treatment initiation; efficacy drops sharply if therapy begins >24 hours after lesion onset 3
• Do not underdose; the 200 mg five-times-daily regimen has poor adherence due to frequent dosing 1, 6
• Do not prescribe insufficient quantity; patients should have medication on hand to start immediately without waiting for a refill 3